PRA Health Sciences anuncia el nombramiento de un nuevo consejero
16 sept. 2020 15h31 HE
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) ha anunciado hoy el nombramiento de Glen Stettin, doctor en medicina, como consejero del...
PRA Health Sciences anuncia nomeação de novo diretor
16 sept. 2020 15h31 HE
|
PRA Health Sciences, Inc.
RALEIGH, Carolina do Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ:PRAH) anunciou hoje a nomeação do Doutor Glen Stettin para o Conselho de Administração da Empresa,...
PRA Health Sciences mengumumkan Pelantikan Pengarah Baharu
16 sept. 2020 15h31 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) hari mengumumkan pelantikan Glen Stettin, M.D. kepada Lembaga Pengarah Syarikat, berkuat kuasa pada 14...
PRA Health Sciences gibt Ernennung eines neuen Verwaltungsratsmitglieds bekannt
16 sept. 2020 15h31 HE
|
PRA Health Sciences, Inc.
RALEIGH, North Carolina, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hat heute die Ernennung von Dr. Glen Stettin zum Verwaltungsratsmitglied des Unternehmens mit...
PRA Health Sciences 宣佈委任新董事
16 sept. 2020 15h31 HE
|
PRA Health Sciences, Inc.
北卡羅萊納州羅利, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) 今天宣佈委任 Glenn Stettin 為公司董事會成員，並於 2020 年 9 月 14 日生效。 PRA health Sciences 董事會主席兼行政總裁 Colin Shannon 說：「我們很高興看到 Glen...
PRA Health Sciences Announces Appointment of New Director
15 sept. 2020 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective...
PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance
06 août 2020 16h01 HE
|
PRA Health Sciences, Inc.
Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million...
PRA Health Sciences to Report Second Quarter 2020 Earnings
02 juil. 2020 13h20 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its second quarter 2020 results after the market closes on Thursday, August 6, 2020. The...
PRA Health Sciences prête à satisfaire les exigences du RACE Act pour l'oncologie pédiatrique
18 juin 2020 16h54 HE
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 18 juin 2020 (GLOBE NEWSWIRE) -- Entre 2007 et 2017, 78 nouveaux agents anticancéreux chez les adultes ont été approuvés par la Food and Drug Administration des...
PRA Health Sciences 準備深入了解《RACE 法案》對兒科腫瘤學的要求
18 juin 2020 16h54 HE
|
PRA Health Sciences, Inc.
北卡羅萊納州拉里市, June 19, 2020 (GLOBE NEWSWIRE) -- 在 2007 年至 2017 年之間，美國食品及藥物監督管理局 (FDA) 共批准了 78 種新的成年癌症藥物，1 但這些藥物均未進行旨在確定其對兒科癌症藥效的研究。 這種情況將在《RACE 法案》（即兒童研究平等法案）於 8 月 18 日生效時發生變化。《RACE 法案》於 2017...